StockResearch Intelligence Weekly #23

Bad News Became Fuel, But Chips Still Cracked — Week Ending July 4, 2026

1. Opening

Last edition’s scoreboard was mixed but useful. Amazon slipped 0.70%, Taiwan Semiconductor fell 6.05%, Exxon held nearly flat at -0.52%, and Chord Energy’s 7.96% drop validated the NO TRADE call. The misses were on the volatility edges: Ambarella rebounded 11.99% after our speculative caution, while Centrus Energy fell 15.29% after we refused to chase. The lesson was clean: quality laggards were manageable, oil-beta stayed weak, and thin AI-adjacent names remained dangerous.

This week flipped the tape. The S&P 500 closed the holiday-shortened week at 7,483.24, up 1.76% from the prior Friday, while the Dow rose 2.49% to 52,900.07 and the Nasdaq gained 2.12% to 25,832.67. July 4 fell on a Saturday, so Independence Day was observed on Friday, July 3; the effective market close for this edition is Thursday, July 2. All weekly numbers below are therefore June 26 to July 2.

The dominant theme was simple: soft labor data became fuel. June nonfarm payrolls rose 57,000 and unemployment was 4.2%, enough to pull rate fear out of the tape without immediately triggering recession panic. That helped software, payments, financials and megacap laggards breathe. It did not save the crowded semiconductor trade.

Key themes this week:

• Bad news became rate-cut fuel. The jobs report was soft enough to calm the hawkish-Fed trade, and the market chose lower-rate optionality over recession fear.
• Software caught a relief bid. IGV rose 6.09%, with Palantir, Salesforce and other reset software names showing that capital is willing to buy growth again when the entry price is lower.
• Semis remained the stress point. SOXX fell 4.00%; Micron, Marvell and several equipment names sold off hard. AI is still investable, but not every AI-adjacent multiple deserves another chase.
• The price-target screen matters more after a bounce. JPMorgan is a high-quality bank with a near-term earnings catalyst, but at $334.47 it is already at its $334.14 mean target. That is a HOLD, not a victory-lap BUY.

2. Strengths

• The index recovered without needing the semiconductor group. The S&P 500 rose 1.76% while SOXX fell 4.00%, which means breadth improved outside the prior leadership complex. Financials rose 3.83%, healthcare rose 2.12%, software rose 6.09%, and consumer staples held positive. That is healthier than a one-theme rally. The detail underneath the sector tape was better than the headline. Visa closed at a new 52-week high, Alphabet rose 6.67%, RTX reclaimed both major moving averages, and Meta bounced while still sitting below its own trend lines. Payments, advertising, defense and software do not all rise for the same fundamental reason. When different business models catch bids in the same week, investors are no longer hiding in one crowded theme. Price improved first; fundamentals still have to confirm.
• Software finally found buyers after months of valuation compression. Salesforce rose 4.89% for the week but still trades at $166.11, below its 50-day moving average of $174.39, its 200-day average of $212.27, and its $265.75 mean consensus target. Palantir’s 14.50% week was more dramatic, but both moves point to the same idea: investors are willing to re-open the software book if the rate path softens. That does not mean every software name is suddenly a BUY. The right question is whether the stock is still below the level where the fundamental debate can be reopened. Salesforce qualifies because the valuation has already been compressed and the consensus target leaves real room. Palantir is more complicated: the weekly move was stronger, but the stock carries a richer multiple and a more emotional investor base.
• Megacap laggards now have cleaner risk-reward than the crowded winners. Meta rose 5.93% but remains down 11.69% year-to-date and trades below both major moving averages. At $582.90 against a $827.50 mean target, the upside gap is still meaningful. That does not make it risk-free; ad budgets and AI spending still matter. But compared with semiconductor names that are up triple digits year-to-date, the risk-reward is less heroic. This is where the price-vs-consensus rule earns its keep. A laggard is not automatically attractive; sometimes it is cheap for a reason. But a laggard with cash flow, platform scale and a large consensus gap is different from a laggard with a broken balance sheet. Meta and Salesforce are in the first camp. JPMorgan is not a laggard at all, which is why it lands as a HOLD despite being a better company than many names we would buy at the right price.

3. Weaknesses

• The semiconductor unwind did not end with last week’s crack. Micron lost 13.84%, Marvell lost 8.05%, Applied Materials fell 3.80%, and Advanced Energy fell 10.58%. This is not a one-stock event. It is a repricing of the most crowded part of the AI trade, and it is happening while the broader index is rising. The temptation is to call every semiconductor decline a buying opportunity because the long-term AI capital cycle remains real. That is too easy. Memory, networking silicon, equipment and power systems have different earnings drivers and different sensitivity to capex timing. We are willing to take one speculative low-cap shot in AEIS, but we are not making semis the core of the edition.
• Small caps did not confirm the relief rally. IWM fell 0.75% and the Russell 2000 slipped 0.46% even as the S&P rose. In a clean lower-rate rally, small caps usually participate more forcefully. Their failure to do so says the market is not simply buying cyclicality; it is buying balance sheets, cash-flow visibility and specific growth franchises.
• The jobs report is not purely bullish. Payroll growth of 57,000 and unemployment at 4.2% help the rate story, but they are not signs of an overheating economy. If the next data points confirm labor softness without a productivity offset, the market can stop treating bad news as good news and start treating it as earnings risk. That is the line to watch next week. The market can handle a softer labor print if it lowers rate pressure and earnings estimates hold. It will be much less forgiving if soft labor data starts to pull down revenue guidance.

4. Weekly Market Recap

5. Top 3 Stock Picks for Long-Term Investment

The new list is deliberately not a semiconductor victory lap. The week gave us a better setup: buy reset growth where consensus still leaves material upside, buy software where the market has already punished the multiple, and hold the financial leader that has reached its target instead of pretending quality alone is an entry point.

1. Meta Platforms (META) – BUY

$582.90 | $1.48T market cap | 17.7x forward P/E (FY26), 16.6x (FY27) | 52W range $520.26-$796.25 | Next earnings: July 29, 2026

1. Thesis. Meta is a megacap growth franchise priced like the market has lost patience with it. The stock rose 5.93% this week, but it remains down 11.69% year-to-date and still sits below both the 50-day moving average ($605.23) and the 200-day moving average ($646.51). That matters: the rebound has not erased the discount. The core ad business remains one of the highest-margin digital platforms in the world, and AI-driven ad tooling gives Meta a direct way to convert infrastructure spending into revenue productivity. The market’s current objection is obvious: if Meta has to spend aggressively on AI infrastructure, near-term margins can look worse before the ad product looks better. That objection is valid, but it is already reflected in the stock’s year-to-date underperformance. The more important question is whether the AI spend has a direct route back to revenue. For Meta, the answer is cleaner than it is for many platform companies. Better targeting, better creative tools and better engagement loops can improve ad pricing and advertiser return on spend. That does not make every dollar of capex good, but it does mean the investment is tied to the core engine rather than a distant optionality story.
2. Why now. At $582.90, Meta trades well below the $827.50 mean consensus target, with the Street range running from $700 to $910. That is about 42% upside to the mean target and roughly 56% to the high end. The internal model is not enthusiastic over seven trading days, projecting -3.00% with 63.15% confidence, so we are not calling for a straight-line move. We are explicitly disagreeing with the model’s near-term caution on horizon: the short-term path may wobble, but the valuation-to-target gap is too large to ignore for a long-term list.
3. Key levels. First resistance is the 50-day at $605, then the 200-day at $647. Support is the recent 52-week low area near $520. The mean target is $827.50; the stretch target is $910.
4. Risks. Ad spending can slow quickly if the labor-market softness becomes a demand problem. AI capex is still a margin debate, and regulatory pressure does not disappear because the stock has pulled back.
5. Verdict: BUY. Accumulate below the 50-day; add only if the stock reclaims $605 with volume. Stop on a close below $520. Target $827.50, stretch $910.

2. Salesforce (CRM) – BUY

$166.11 | $136.0B market cap | 14.1x forward P/E (FY26), 11.7x (FY27) | 52W range $146.32-$276.80 | Next earnings: September 2, 2026

1. Thesis. Salesforce is the software reset in one ticker. It is down 37.30% year-to-date, trades below the 50-day moving average of $174.39 and far below the 200-day of $212.27, yet the consensus target remains $265.75. That combination is rare: a profitable software platform with a beaten-down multiple and a large target gap. The business is not as exciting as the newest AI infrastructure story, but customer data, workflow automation and enterprise distribution are still durable assets. The boring quality is part of the appeal. Salesforce is not trying to convince the market that a future product category will exist; it already owns large enterprise workflows and customer relationships. The bear case is that AI compresses software seats and pressures legacy SaaS pricing. The bull case is that AI makes trusted data systems more valuable, not less, because automation needs governed customer records and workflow context. At this price, we do not need the bull case to be spectacular. We need the business to remain relevant and the multiple to stop contracting.
2. Why now. The stock rose 4.89% this week as software caught a rate-relief bid, but the move barely dented the drawdown. At $166.11, Salesforce trades about 60% below its mean target. The internal model is constructive over three trading days, projecting +2.62% with 63.63% confidence, while the seven-day read is neutral. That matches the setup: the bounce can continue, but the thesis is not a one-week model trade. It is a valuation reset in a cash-generative software name.
3. Key levels. The 50-day at $174 is the first hurdle. The 200-day at $212 is the real re-rating line. The mean target is $265.75, and the Street high is $325.
4. Risks. Enterprise software budgets can get cut if labor softness turns into recession concern. AI-native competitors remain a real narrative overhang, and management has to keep proving margin discipline.
5. Verdict: BUY. Buy the reset, not the bounce. Stop on a close below $146. Target $265.75, stretch $325.

3. JPMorgan Chase (JPM) – HOLD

$334.47 | $896.2B market cap | 14.8x forward P/E (FY26), 14.1x (FY27) | 52W range $279.10-$343.45 | Next earnings: July 14, 2026

1. Thesis. JPMorgan is still the best large-bank franchise in the market: scale, deposit depth, trading revenue, credit discipline and capital return. Financials were one of the week’s strongest groups, with XLF up 3.83%, and JPM rose 1.65% into its July 14 earnings report. The company deserves a premium multiple relative to peers. The problem is not the company. It is the entry. This is exactly the sort of situation where investors talk themselves into buying a great business at a full price because the story is easy to defend. We would rather be more mechanical. The mean target is $334.14; the stock is $334.47. That does not mean JPM cannot go higher, and the Street high of $361 leaves upside if estimates rise. It means the current public consensus no longer gives us enough margin to recommend fresh buying before earnings. Good company, fair price, HOLD.
2. Why now — and why not a BUY. The price-target screen makes this decision for us. JPM closed at $334.47; its mean consensus target is $334.14. That means the stock is already slightly above the mean target. The Street high is $361, but we do not underwrite a BUY on high-target math alone. The internal model sees modest upside over seven trading days, +1.36% with 54.51% confidence, but that is not strong enough to override valuation discipline.
3. Key levels. Support sits near the 50-day at $312.61 and the 200-day at $308.49. The 52-week high is $343.45, and the target range is $295-$361.
4. Risks. Credit costs can rise if the labor market keeps softening, and a flatter curve can pressure net interest income. Into earnings, the setup is more execution-sensitive than cheap.
5. Verdict: HOLD. Own it if you have it; do not chase a new position at the mean target. Revisit on a pullback toward $312 or if consensus targets move up after earnings.

6. Low-Cap Opportunities

1. Advanced Energy Industries (AEIS) — $311.27 | $11.8B market cap | 33.1x forward P/E (FY26), 25.8x (FY27) | 52W range $128.40-$397.44 | Next earnings: August 4, 2026. Advanced Energy makes precision power-conversion systems used across semiconductor equipment, industrial and data-center applications. The stock fell 10.58% this week, which is the reason it is interesting and the reason it is risky. It remains above the 200-day moving average at $274.53, but below the 50-day at $344.77; the mean target is $424.29, roughly 36% above the July 2 close. Verdict: SPEC. BUY. This is a semicap pullback trade, not a core holding. Stop below $274. Target $424, stretch $500 only if semicap orders stabilize.

The case here is not that the semiconductor selloff is over. It may not be. The case is that AEIS gives us a smaller, more focused way to express a rebound in power and equipment demand after a sharp reset, while still keeping the risk label honest. The 200-day is the line that keeps the chart from becoming broken. If that fails, the thesis moves from “reset” to “falling knife,” and we step aside.

2. Celsius Holdings (CELH) — $33.16 | $8.5B market cap | 20.5x forward P/E (FY26), 16.6x (FY27) | 52W range $27.47-$66.74 | Next earnings: August 6, 2026. Celsius gives us consumer growth without paying a software multiple. The stock rose 11.09% this week, but it is still down 27.50% year-to-date and trades below its 200-day moving average. The mean target is $49.57, about 49.5% above the close. Verdict: BUY. The bounce is not early, so size it carefully, but the valuation-to-growth setup is cleaner than most low-cap consumer names. Stop below $27. Target $49.50.

The risk is that a soft labor market eventually pressures discretionary consumption. That is why we prefer a defined target and a stop near the 52-week low rather than an open-ended growth call. But compared with many low-cap software and speculative hardware names, Celsius has a simpler question to answer: is demand still growing fast enough to justify the forward multiple? If the August report says yes, the target gap is meaningful.

3. Enphase Energy (ENPH) — $43.07 | $5.7B market cap | 21.3x forward P/E (FY26), 18.5x (FY27) | 52W range $25.78-$73.74 | Next earnings: July 28, 2026. Enphase is tempting because solar has already been crushed and the stock is only a few dollars above its 200-day average. The problem is the target screen and the tape: it fell 9.48% this week, sits below the 50-day, and the mean target is $47.61, only 10.5% above the close. Verdict: NO TRADE. A 10% target gap is not enough compensation for a broken group. Wait for earnings or a higher target reset.

This is not a negative view on the technology or even a permanent negative view on the company. It is a rejection of the setup. A stock can look washed out and still not be cheap enough. For Enphase, the chart is unstable, the sector is not leading, and the consensus target does not offer enough reward for taking the volatility. That is what NO TRADE is for: not hatred, just math.

7. Strategic Recap & Forward Outlook

This is not the same tape as last week. The prior edition punished almost every risk asset tied to AI momentum. This week, the market separated the winners from the crowded trades: software and payments bounced, megacap laggards recovered, banks held firm, and the semiconductor complex kept bleeding. That is a better market for stock selection and a worse market for autopilot exposure.

Our response is to buy where the target gap is real and the valuation has reset: Meta and Salesforce. We hold JPMorgan because the business is excellent but the stock is already at its mean target. In low caps, we take risk only where the upside compensates us: AEIS as a speculative semicap reset, Celsius as a consumer-growth rebound, and no trade on Enphase until the numbers improve. The tape gave us rate relief; it did not give us permission to forget price.

Forward Outlook

• Monday, July 6 — Markets reopen after the observed Independence Day closure; watch whether software follow-through survives the long weekend.
• Tuesday, July 7 — Positioning reset ahead of midweek Fed communication; watch small caps for confirmation or rejection of the rate-relief trade.
• Wednesday, July 8 — FOMC minutes are the key macro checkpoint for how seriously the Committee views labor softness versus inflation risk.
• Thursday, July 9 — Weekly jobless claims test whether the payroll slowdown is noise or trend.
• Friday, July 10 — End-of-week breadth check before bank earnings begin the following week; JPM reports Tuesday, July 14.

Disclaimer: StockResearch Intelligence Weekly is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. All data is sourced from third-party providers and believed accurate as of the publication date but is not guaranteed. Price targets and verdicts reflect the author’s analysis and may change without notice. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Conduct your own research and consult a licensed financial advisor before making investment decisions. The author may hold positions in securities mentioned.